DNMT3A and disease recurrence: In this study, the associations between methylation markers (DNMT1, DNMT3A, and DNMT3B) and both locoregional recurrent disease and disease-specific mortality in patients with locally advanced LSCC treated with definitive, curatively intended radiotherapy alone was investigated.